nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—TOP2A—Epirubicin—pancreatic cancer	0.208	0.32	CbGbCtD
Amsacrine—TOP2A—Doxorubicin—pancreatic cancer	0.11	0.17	CbGbCtD
Amsacrine—KCNH2—Sunitinib—pancreatic cancer	0.079	0.122	CbGbCtD
Amsacrine—ABCB1—Tamoxifen—pancreatic cancer	0.0352	0.0542	CbGbCtD
Amsacrine—CYP2D6—Tamoxifen—pancreatic cancer	0.0332	0.0511	CbGbCtD
Amsacrine—ABCB1—Gemcitabine—pancreatic cancer	0.0303	0.0467	CbGbCtD
Amsacrine—ABCB1—Erlotinib—pancreatic cancer	0.0299	0.0461	CbGbCtD
Amsacrine—CYP2D6—Erlotinib—pancreatic cancer	0.0282	0.0434	CbGbCtD
Amsacrine—ABCB1—Irinotecan—pancreatic cancer	0.027	0.0416	CbGbCtD
Amsacrine—ABCB1—Docetaxel—pancreatic cancer	0.0198	0.0305	CbGbCtD
Amsacrine—ABCB1—Sunitinib—pancreatic cancer	0.0197	0.0304	CbGbCtD
Amsacrine—ABCB1—Doxorubicin—pancreatic cancer	0.0148	0.0227	CbGbCtD
Amsacrine—CYP2D6—Doxorubicin—pancreatic cancer	0.0139	0.0214	CbGbCtD
Amsacrine—NCOA3—Topotecan—Irinotecan—pancreatic cancer	0.00396	0.494	CbGdCrCtD
Amsacrine—NCOA3—Idarubicin—Epirubicin—pancreatic cancer	0.000931	0.116	CbGdCrCtD
Amsacrine—NCOA3—Idarubicin—Doxorubicin—pancreatic cancer	0.000862	0.107	CbGdCrCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—SMAD4—pancreatic cancer	0.000594	0.00751	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.000586	0.00742	CbGpPWpGaD
Amsacrine—NCOA3—Validated nuclear estrogen receptor alpha network—CCND1—pancreatic cancer	0.000583	0.00738	CbGpPWpGaD
Amsacrine—TOP2A—Topotecan—Irinotecan—pancreatic cancer	0.000544	0.0678	CbGdCrCtD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—NOTCH1—pancreatic cancer	0.000536	0.00679	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000536	0.00679	CbGpPWpGaD
Amsacrine—NCOA3—PPARA activates gene expression—PPARG—pancreatic cancer	0.000532	0.00674	CbGpPWpGaD
Amsacrine—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—pancreatic cancer	0.000521	0.00659	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—SYCP1—pancreatic cancer	0.000496	0.00628	CbGpPWpGaD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—pancreatic cancer	0.000488	0.00618	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—NRP1—pancreatic cancer	0.000486	0.00616	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—TSC2—pancreatic cancer	0.000484	0.00613	CbGpPWpGaD
Amsacrine—NCOA3—Validated nuclear estrogen receptor alpha network—MYC—pancreatic cancer	0.000468	0.00592	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.000461	0.00584	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 2—CTNNB1—pancreatic cancer	0.000452	0.00573	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—CCND1—pancreatic cancer	0.000448	0.00567	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—CTNNB1—pancreatic cancer	0.000444	0.00562	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—PTEN—pancreatic cancer	0.000432	0.00547	CbGpPWpGaD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—TGFB1—pancreatic cancer	0.000403	0.0051	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—SRC—pancreatic cancer	0.000401	0.00508	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—EGF—pancreatic cancer	0.0004	0.00506	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	0.000397	0.00503	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.000395	0.005	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.000394	0.00499	CbGpPWpGaD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—pancreatic cancer	0.000387	0.00491	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—STAT3—pancreatic cancer	0.000387	0.0049	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—NDRG1—pancreatic cancer	0.000384	0.00486	CbGpPWpGaD
Amsacrine—TOP2A—Paclitaxel—Docetaxel—pancreatic cancer	0.000382	0.0476	CbGdCrCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000378	0.00478	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—SLC2A2—pancreatic cancer	0.000376	0.00476	CbGpPWpGaD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—TNF—pancreatic cancer	0.000376	0.00476	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—AHR—pancreatic cancer	0.000372	0.00471	CbGpPWpGaD
Amsacrine—TOP2A—Gefitinib—Erlotinib—pancreatic cancer	0.000367	0.0457	CbGdCrCtD
Amsacrine—TOP2A—Gastric Cancer Network 2—MYC—pancreatic cancer	0.000366	0.00464	CbGpPWpGaD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—pancreatic cancer	0.000359	0.00454	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 2—EGFR—pancreatic cancer	0.000358	0.00454	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—IAPP—pancreatic cancer	0.000357	0.00452	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—EGFR—pancreatic cancer	0.000351	0.00445	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000339	0.00429	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000335	0.00424	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.000334	0.00422	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	0.000302	0.00382	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 2—TP53—pancreatic cancer	0.000301	0.00381	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	0.000294	0.00372	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000292	0.0037	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	0.000291	0.00368	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000287	0.00364	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	0.000283	0.00359	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—pancreatic cancer	0.000281	0.00356	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—EZH2—pancreatic cancer	0.000281	0.00355	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—TYMS—pancreatic cancer	0.00028	0.00354	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	0.000269	0.00341	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—PTEN—pancreatic cancer	0.000268	0.00339	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PRSS1—pancreatic cancer	0.000262	0.00332	CbGpPWpGaD
Amsacrine—Diarrhoea—Erlotinib—pancreatic cancer	0.00026	0.000985	CcSEcCtD
Amsacrine—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000259	0.000982	CcSEcCtD
Amsacrine—Urethral disorder—Docetaxel—pancreatic cancer	0.000258	0.000979	CcSEcCtD
Amsacrine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000258	0.000979	CcSEcCtD
Amsacrine—Anorexia—Irinotecan—pancreatic cancer	0.000258	0.000979	CcSEcCtD
Amsacrine—Infection—Fluorouracil—pancreatic cancer	0.000257	0.000977	CcSEcCtD
Amsacrine—Skin disorder—Gemcitabine—pancreatic cancer	0.000256	0.000971	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.000256	0.00324	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—RBBP8—pancreatic cancer	0.000254	0.00321	CbGpPWpGaD
Amsacrine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000254	0.000963	CcSEcCtD
Amsacrine—Dizziness—Tamoxifen—pancreatic cancer	0.000254	0.000962	CcSEcCtD
Amsacrine—Tachycardia—Fluorouracil—pancreatic cancer	0.000253	0.00096	CcSEcCtD
Amsacrine—Hypotension—Irinotecan—pancreatic cancer	0.000253	0.000959	CcSEcCtD
Amsacrine—Affect lability—Epirubicin—pancreatic cancer	0.000253	0.000959	CcSEcCtD
Amsacrine—Anorexia—Gemcitabine—pancreatic cancer	0.000251	0.000953	CcSEcCtD
Amsacrine—Dizziness—Erlotinib—pancreatic cancer	0.000251	0.000952	CcSEcCtD
Amsacrine—NCOA3—Androgen receptor signaling pathway—AKT1—pancreatic cancer	0.000249	0.00316	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—SRC—pancreatic cancer	0.000248	0.00314	CbGpPWpGaD
Amsacrine—Anorexia—Fluorouracil—pancreatic cancer	0.000247	0.000937	CcSEcCtD
Amsacrine—Purpura—Doxorubicin—pancreatic cancer	0.000246	0.000935	CcSEcCtD
Amsacrine—Hypotension—Gemcitabine—pancreatic cancer	0.000246	0.000934	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000246	0.00312	CbGpPWpGaD
Amsacrine—Cardiac disorder—Docetaxel—pancreatic cancer	0.000244	0.000927	CcSEcCtD
Amsacrine—Vomiting—Tamoxifen—pancreatic cancer	0.000244	0.000925	CcSEcCtD
Amsacrine—Mood swings—Epirubicin—pancreatic cancer	0.000243	0.000923	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000243	0.00308	CbGpPWpGaD
Amsacrine—Paraesthesia—Irinotecan—pancreatic cancer	0.000243	0.000922	CcSEcCtD
Amsacrine—Lethargy—Doxorubicin—pancreatic cancer	0.000242	0.00092	CcSEcCtD
Amsacrine—Hypotension—Fluorouracil—pancreatic cancer	0.000242	0.000919	CcSEcCtD
Amsacrine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000242	0.000918	CcSEcCtD
Amsacrine—Rash—Tamoxifen—pancreatic cancer	0.000242	0.000917	CcSEcCtD
Amsacrine—Dermatitis—Tamoxifen—pancreatic cancer	0.000242	0.000917	CcSEcCtD
Amsacrine—CYP2D6—Melatonin metabolism and effects—APOE—pancreatic cancer	0.000241	0.00306	CbGpPWpGaD
Amsacrine—Vomiting—Erlotinib—pancreatic cancer	0.000241	0.000915	CcSEcCtD
Amsacrine—Dyspnoea—Irinotecan—pancreatic cancer	0.000241	0.000915	CcSEcCtD
Amsacrine—Blood creatinine increased—Epirubicin—pancreatic cancer	0.00024	0.000912	CcSEcCtD
Amsacrine—Headache—Tamoxifen—pancreatic cancer	0.00024	0.000912	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—STAT3—pancreatic cancer	0.000239	0.00303	CbGpPWpGaD
Amsacrine—Rash—Erlotinib—pancreatic cancer	0.000239	0.000908	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.000239	0.00303	CbGpPWpGaD
Amsacrine—Dermatitis—Erlotinib—pancreatic cancer	0.000239	0.000907	CcSEcCtD
Amsacrine—Angiopathy—Docetaxel—pancreatic cancer	0.000239	0.000906	CcSEcCtD
Amsacrine—Headache—Erlotinib—pancreatic cancer	0.000238	0.000902	CcSEcCtD
Amsacrine—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000237	0.0009	CcSEcCtD
Amsacrine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000237	0.000898	CcSEcCtD
Amsacrine—Asthenia—Sunitinib—pancreatic cancer	0.000236	0.000894	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	0.000235	0.00298	CbGpPWpGaD
Amsacrine—Decreased appetite—Irinotecan—pancreatic cancer	0.000235	0.000892	CcSEcCtD
Amsacrine—Arrhythmia—Docetaxel—pancreatic cancer	0.000235	0.000892	CcSEcCtD
Amsacrine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000235	0.000892	CcSEcCtD
Amsacrine—Affect lability—Doxorubicin—pancreatic cancer	0.000234	0.000887	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000234	0.000886	CcSEcCtD
Amsacrine—Fatigue—Irinotecan—pancreatic cancer	0.000233	0.000885	CcSEcCtD
Amsacrine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000233	0.000883	CcSEcCtD
Amsacrine—Alopecia—Docetaxel—pancreatic cancer	0.000233	0.000883	CcSEcCtD
Amsacrine—Pain—Irinotecan—pancreatic cancer	0.000231	0.000878	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000231	0.000877	CcSEcCtD
Amsacrine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000231	0.000877	CcSEcCtD
Amsacrine—Mental disorder—Docetaxel—pancreatic cancer	0.000231	0.000875	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	0.00023	0.00292	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—SMAD4—pancreatic cancer	0.00023	0.00291	CbGpPWpGaD
Amsacrine—Malnutrition—Docetaxel—pancreatic cancer	0.000229	0.00087	CcSEcCtD
Amsacrine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000229	0.000869	CcSEcCtD
Amsacrine—Nausea—Tamoxifen—pancreatic cancer	0.000228	0.000864	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000228	0.000863	CcSEcCtD
Amsacrine—NCOA3—Metabolism—ARG2—pancreatic cancer	0.000227	0.00288	CbGpPWpGaD
Amsacrine—Fatigue—Gemcitabine—pancreatic cancer	0.000227	0.000862	CcSEcCtD
Amsacrine—Pain—Gemcitabine—pancreatic cancer	0.000225	0.000855	CcSEcCtD
Amsacrine—Nausea—Erlotinib—pancreatic cancer	0.000225	0.000855	CcSEcCtD
Amsacrine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000225	0.000855	CcSEcCtD
Amsacrine—Mood swings—Doxorubicin—pancreatic cancer	0.000225	0.000854	CcSEcCtD
Amsacrine—Diarrhoea—Sunitinib—pancreatic cancer	0.000225	0.000853	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—HES1—pancreatic cancer	0.000225	0.00284	CbGpPWpGaD
Amsacrine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000224	0.000849	CcSEcCtD
Amsacrine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000223	0.000846	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000223	0.00282	CbGpPWpGaD
Amsacrine—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000222	0.000844	CcSEcCtD
Amsacrine—Dysphagia—Epirubicin—pancreatic cancer	0.000222	0.000842	CcSEcCtD
Amsacrine—Pain—Fluorouracil—pancreatic cancer	0.000222	0.000841	CcSEcCtD
Amsacrine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000221	0.000839	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	0.000221	0.00279	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—EGFR—pancreatic cancer	0.000218	0.00276	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	0.000218	0.00275	CbGpPWpGaD
Amsacrine—Dizziness—Sunitinib—pancreatic cancer	0.000217	0.000824	CcSEcCtD
Amsacrine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000217	0.000824	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000216	0.00273	CbGpPWpGaD
Amsacrine—Body temperature increased—Irinotecan—pancreatic cancer	0.000214	0.000812	CcSEcCtD
Amsacrine—Abdominal pain—Irinotecan—pancreatic cancer	0.000214	0.000812	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000214	0.000811	CcSEcCtD
Amsacrine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000214	0.00081	CcSEcCtD
Amsacrine—Anaemia—Docetaxel—pancreatic cancer	0.000212	0.000804	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000212	0.00268	CbGpPWpGaD
Amsacrine—Pancytopenia—Epirubicin—pancreatic cancer	0.000211	0.000799	CcSEcCtD
Amsacrine—Vomiting—Sunitinib—pancreatic cancer	0.000209	0.000792	CcSEcCtD
Amsacrine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000208	0.000791	CcSEcCtD
Amsacrine—Rash—Sunitinib—pancreatic cancer	0.000207	0.000786	CcSEcCtD
Amsacrine—Dermatitis—Sunitinib—pancreatic cancer	0.000207	0.000785	CcSEcCtD
Amsacrine—Urticaria—Fluorouracil—pancreatic cancer	0.000206	0.000781	CcSEcCtD
Amsacrine—Headache—Sunitinib—pancreatic cancer	0.000206	0.000781	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—KRAS—pancreatic cancer	0.000206	0.0026	CbGpPWpGaD
Amsacrine—Dysphagia—Doxorubicin—pancreatic cancer	0.000205	0.000779	CcSEcCtD
Amsacrine—Leukopenia—Docetaxel—pancreatic cancer	0.000205	0.000778	CcSEcCtD
Amsacrine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000205	0.000777	CcSEcCtD
Amsacrine—TOP2A—Circadian rythm related genes—TYMS—pancreatic cancer	0.000203	0.00257	CbGpPWpGaD
Amsacrine—Weight increased—Epirubicin—pancreatic cancer	0.000202	0.000766	CcSEcCtD
Amsacrine—Weight decreased—Epirubicin—pancreatic cancer	0.000201	0.000762	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.0002	0.00254	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	0.0002	0.00253	CbGpPWpGaD
Amsacrine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000199	0.000756	CcSEcCtD
Amsacrine—NCOA3—Metabolism—TYMP—pancreatic cancer	0.000199	0.00252	CbGpPWpGaD
Amsacrine—Convulsion—Docetaxel—pancreatic cancer	0.000199	0.000753	CcSEcCtD
Amsacrine—Infestation NOS—Epirubicin—pancreatic cancer	0.000198	0.000751	CcSEcCtD
Amsacrine—Infestation—Epirubicin—pancreatic cancer	0.000198	0.000751	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—PPP2R5B—pancreatic cancer	0.000197	0.0025	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	0.000197	0.00249	CbGpPWpGaD
Amsacrine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000196	0.00249	CbGpPWpGaD
Amsacrine—Nausea—Sunitinib—pancreatic cancer	0.000195	0.00074	CcSEcCtD
Amsacrine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000195	0.00074	CcSEcCtD
Amsacrine—Renal failure—Epirubicin—pancreatic cancer	0.000194	0.000738	CcSEcCtD
Amsacrine—Asthenia—Irinotecan—pancreatic cancer	0.000194	0.000737	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000194	0.000735	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	0.000193	0.00245	CbGpPWpGaD
Amsacrine—Jaundice—Epirubicin—pancreatic cancer	0.000193	0.000732	CcSEcCtD
Amsacrine—Stomatitis—Epirubicin—pancreatic cancer	0.000193	0.000732	CcSEcCtD
Amsacrine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000191	0.000724	CcSEcCtD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—RB1—pancreatic cancer	0.00019	0.0024	CbGpPWpGaD
Amsacrine—Asthenia—Gemcitabine—pancreatic cancer	0.000189	0.000717	CcSEcCtD
Amsacrine—Haematuria—Epirubicin—pancreatic cancer	0.000189	0.000716	CcSEcCtD
Amsacrine—Confusional state—Docetaxel—pancreatic cancer	0.000189	0.000716	CcSEcCtD
Amsacrine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000187	0.00071	CcSEcCtD
Amsacrine—Weight increased—Doxorubicin—pancreatic cancer	0.000187	0.000709	CcSEcCtD
Amsacrine—Infection—Docetaxel—pancreatic cancer	0.000186	0.000705	CcSEcCtD
Amsacrine—Weight decreased—Doxorubicin—pancreatic cancer	0.000186	0.000705	CcSEcCtD
Amsacrine—Diarrhoea—Irinotecan—pancreatic cancer	0.000185	0.000702	CcSEcCtD
Amsacrine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000185	0.0007	CcSEcCtD
Amsacrine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000183	0.000695	CcSEcCtD
Amsacrine—Infestation NOS—Doxorubicin—pancreatic cancer	0.000183	0.000694	CcSEcCtD
Amsacrine—Infestation—Doxorubicin—pancreatic cancer	0.000183	0.000694	CcSEcCtD
Amsacrine—Tachycardia—Docetaxel—pancreatic cancer	0.000183	0.000693	CcSEcCtD
Amsacrine—Skin disorder—Docetaxel—pancreatic cancer	0.000182	0.000689	CcSEcCtD
Amsacrine—Bradycardia—Epirubicin—pancreatic cancer	0.000181	0.000686	CcSEcCtD
Amsacrine—Diarrhoea—Gemcitabine—pancreatic cancer	0.00018	0.000684	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—KDR—pancreatic cancer	0.00018	0.00228	CbGpPWpGaD
Amsacrine—Renal failure—Doxorubicin—pancreatic cancer	0.00018	0.000683	CcSEcCtD
Amsacrine—Dizziness—Irinotecan—pancreatic cancer	0.000179	0.000679	CcSEcCtD
Amsacrine—Haemoglobin—Epirubicin—pancreatic cancer	0.000178	0.000677	CcSEcCtD
Amsacrine—Jaundice—Doxorubicin—pancreatic cancer	0.000178	0.000677	CcSEcCtD
Amsacrine—Stomatitis—Doxorubicin—pancreatic cancer	0.000178	0.000677	CcSEcCtD
Amsacrine—Anorexia—Docetaxel—pancreatic cancer	0.000178	0.000676	CcSEcCtD
Amsacrine—Haemorrhage—Epirubicin—pancreatic cancer	0.000178	0.000674	CcSEcCtD
Amsacrine—Hepatitis—Epirubicin—pancreatic cancer	0.000178	0.000674	CcSEcCtD
Amsacrine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000177	0.000673	CcSEcCtD
Amsacrine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000177	0.00067	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000177	0.00224	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MET—pancreatic cancer	0.000176	0.00223	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—FOXM1—pancreatic cancer	0.000176	0.00223	CbGpPWpGaD
Amsacrine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000175	0.000665	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—HRAS—pancreatic cancer	0.000175	0.00221	CbGpPWpGaD
Amsacrine—Hypotension—Docetaxel—pancreatic cancer	0.000175	0.000663	CcSEcCtD
Amsacrine—Haematuria—Doxorubicin—pancreatic cancer	0.000175	0.000662	CcSEcCtD
Amsacrine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000174	0.000662	CcSEcCtD
Amsacrine—Urethral disorder—Epirubicin—pancreatic cancer	0.000174	0.00066	CcSEcCtD
Amsacrine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000173	0.000657	CcSEcCtD
Amsacrine—Vomiting—Irinotecan—pancreatic cancer	0.000172	0.000653	CcSEcCtD
Amsacrine—Dizziness—Fluorouracil—pancreatic cancer	0.000171	0.00065	CcSEcCtD
Amsacrine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000171	0.000648	CcSEcCtD
Amsacrine—Rash—Irinotecan—pancreatic cancer	0.000171	0.000647	CcSEcCtD
Amsacrine—Dermatitis—Irinotecan—pancreatic cancer	0.00017	0.000647	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—NOTCH1—pancreatic cancer	0.00017	0.00215	CbGpPWpGaD
Amsacrine—Headache—Irinotecan—pancreatic cancer	0.00017	0.000643	CcSEcCtD
Amsacrine—Paraesthesia—Docetaxel—pancreatic cancer	0.000168	0.000637	CcSEcCtD
Amsacrine—Vomiting—Gemcitabine—pancreatic cancer	0.000168	0.000636	CcSEcCtD
Amsacrine—Bradycardia—Doxorubicin—pancreatic cancer	0.000167	0.000635	CcSEcCtD
Amsacrine—Dyspnoea—Docetaxel—pancreatic cancer	0.000167	0.000633	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—AGTR1—pancreatic cancer	0.000167	0.00211	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CDKN2A—pancreatic cancer	0.000167	0.00211	CbGpPWpGaD
Amsacrine—Rash—Gemcitabine—pancreatic cancer	0.000166	0.000631	CcSEcCtD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	0.000166	0.0021	CbGpPWpGaD
Amsacrine—Dermatitis—Gemcitabine—pancreatic cancer	0.000166	0.00063	CcSEcCtD
Amsacrine—Haemoglobin—Doxorubicin—pancreatic cancer	0.000165	0.000627	CcSEcCtD
Amsacrine—Headache—Gemcitabine—pancreatic cancer	0.000165	0.000626	CcSEcCtD
Amsacrine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000165	0.000625	CcSEcCtD
Amsacrine—Vomiting—Fluorouracil—pancreatic cancer	0.000165	0.000625	CcSEcCtD
Amsacrine—Haemorrhage—Doxorubicin—pancreatic cancer	0.000164	0.000623	CcSEcCtD
Amsacrine—Hepatitis—Doxorubicin—pancreatic cancer	0.000164	0.000623	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000164	0.00208	CbGpPWpGaD
Amsacrine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000163	0.00062	CcSEcCtD
Amsacrine—Rash—Fluorouracil—pancreatic cancer	0.000163	0.00062	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	0.000163	0.00207	CbGpPWpGaD
Amsacrine—Dermatitis—Fluorouracil—pancreatic cancer	0.000163	0.000619	CcSEcCtD
Amsacrine—Decreased appetite—Docetaxel—pancreatic cancer	0.000163	0.000617	CcSEcCtD
Amsacrine—Headache—Fluorouracil—pancreatic cancer	0.000162	0.000616	CcSEcCtD
Amsacrine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000162	0.000616	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000161	0.000613	CcSEcCtD
Amsacrine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000161	0.000613	CcSEcCtD
Amsacrine—Fatigue—Docetaxel—pancreatic cancer	0.000161	0.000612	CcSEcCtD
Amsacrine—Angiopathy—Epirubicin—pancreatic cancer	0.000161	0.000611	CcSEcCtD
Amsacrine—Urethral disorder—Doxorubicin—pancreatic cancer	0.000161	0.000611	CcSEcCtD
Amsacrine—Nausea—Irinotecan—pancreatic cancer	0.000161	0.00061	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.00016	0.00203	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	0.00016	0.00203	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GLP1R—pancreatic cancer	0.00016	0.00203	CbGpPWpGaD
Amsacrine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00016	0.000607	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—PPARG—pancreatic cancer	0.00016	0.00203	CbGpPWpGaD
Amsacrine—Pain—Docetaxel—pancreatic cancer	0.00016	0.000607	CcSEcCtD
Amsacrine—Arrhythmia—Epirubicin—pancreatic cancer	0.000159	0.000602	CcSEcCtD
Amsacrine—NCOA3—Metabolism—DPYD—pancreatic cancer	0.000158	0.002	CbGpPWpGaD
Amsacrine—Alopecia—Epirubicin—pancreatic cancer	0.000157	0.000595	CcSEcCtD
Amsacrine—Nausea—Gemcitabine—pancreatic cancer	0.000157	0.000594	CcSEcCtD
Amsacrine—Mental disorder—Epirubicin—pancreatic cancer	0.000156	0.00059	CcSEcCtD
Amsacrine—Malnutrition—Epirubicin—pancreatic cancer	0.000155	0.000586	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—AKT1—pancreatic cancer	0.000154	0.00195	CbGpPWpGaD
Amsacrine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000154	0.000585	CcSEcCtD
Amsacrine—Nausea—Fluorouracil—pancreatic cancer	0.000154	0.000584	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000154	0.00195	CbGpPWpGaD
Amsacrine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000153	0.00058	CcSEcCtD
Amsacrine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000152	0.000579	CcSEcCtD
Amsacrine—ABCB1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00015	0.0019	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—SLC2A2—pancreatic cancer	0.00015	0.00189	CbGpPWpGaD
Amsacrine—Angiopathy—Doxorubicin—pancreatic cancer	0.000149	0.000566	CcSEcCtD
Amsacrine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000148	0.000562	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000148	0.00187	CbGpPWpGaD
Amsacrine—Body temperature increased—Docetaxel—pancreatic cancer	0.000148	0.000561	CcSEcCtD
Amsacrine—Abdominal pain—Docetaxel—pancreatic cancer	0.000148	0.000561	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—MMP2—pancreatic cancer	0.000147	0.00186	CbGpPWpGaD
Amsacrine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000147	0.000557	CcSEcCtD
Amsacrine—Vision blurred—Epirubicin—pancreatic cancer	0.000146	0.000553	CcSEcCtD
Amsacrine—Alopecia—Doxorubicin—pancreatic cancer	0.000145	0.000551	CcSEcCtD
Amsacrine—TOP2A—Circadian rythm related genes—PPARG—pancreatic cancer	0.000144	0.00182	CbGpPWpGaD
Amsacrine—Mental disorder—Doxorubicin—pancreatic cancer	0.000144	0.000546	CcSEcCtD
Amsacrine—Malnutrition—Doxorubicin—pancreatic cancer	0.000143	0.000543	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.000143	0.00181	CbGpPWpGaD
Amsacrine—Anaemia—Epirubicin—pancreatic cancer	0.000143	0.000542	CcSEcCtD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	0.000142	0.0018	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CCND1—pancreatic cancer	0.000141	0.00178	CbGpPWpGaD
Amsacrine—Leukopenia—Epirubicin—pancreatic cancer	0.000138	0.000525	CcSEcCtD
Amsacrine—TOP2A—Cytarabine—Gemcitabine—pancreatic cancer	0.000138	0.0172	CbGdCrCtD
Amsacrine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000138	0.000523	CcSEcCtD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	0.000136	0.00172	CbGpPWpGaD
Amsacrine—Vision blurred—Doxorubicin—pancreatic cancer	0.000135	0.000511	CcSEcCtD
Amsacrine—Asthenia—Docetaxel—pancreatic cancer	0.000134	0.000509	CcSEcCtD
Amsacrine—Convulsion—Epirubicin—pancreatic cancer	0.000134	0.000508	CcSEcCtD
Amsacrine—Anaemia—Doxorubicin—pancreatic cancer	0.000132	0.000502	CcSEcCtD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	0.000132	0.00167	CbGpPWpGaD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000131	0.000496	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.00013	0.00165	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.00013	0.00165	CbGpPWpGaD
Amsacrine—Leukopenia—Doxorubicin—pancreatic cancer	0.000128	0.000486	CcSEcCtD
Amsacrine—Diarrhoea—Docetaxel—pancreatic cancer	0.000128	0.000486	CcSEcCtD
Amsacrine—TOP2A—Doxorubicin—Epirubicin—pancreatic cancer	0.000128	0.0159	CbGdCrCtD
Amsacrine—TOP2A—Daunorubicin—Epirubicin—pancreatic cancer	0.000128	0.0159	CbGdCrCtD
Amsacrine—TOP2A—Idarubicin—Epirubicin—pancreatic cancer	0.000128	0.0159	CbGdCrCtD
Amsacrine—Confusional state—Epirubicin—pancreatic cancer	0.000127	0.000483	CcSEcCtD
Amsacrine—Infection—Epirubicin—pancreatic cancer	0.000125	0.000476	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000124	0.00157	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000124	0.00157	CbGpPWpGaD
Amsacrine—Convulsion—Doxorubicin—pancreatic cancer	0.000124	0.00047	CcSEcCtD
Amsacrine—Dizziness—Docetaxel—pancreatic cancer	0.000124	0.000469	CcSEcCtD
Amsacrine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000124	0.000469	CcSEcCtD
Amsacrine—Tachycardia—Epirubicin—pancreatic cancer	0.000123	0.000467	CcSEcCtD
Amsacrine—Skin disorder—Epirubicin—pancreatic cancer	0.000123	0.000465	CcSEcCtD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000122	0.00155	CbGpPWpGaD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000121	0.000459	CcSEcCtD
Amsacrine—Anorexia—Epirubicin—pancreatic cancer	0.00012	0.000456	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.00012	0.00152	CbGpPWpGaD
Amsacrine—Vomiting—Docetaxel—pancreatic cancer	0.000119	0.000451	CcSEcCtD
Amsacrine—TOP2A—Epirubicin—Doxorubicin—pancreatic cancer	0.000118	0.0148	CbGdCrCtD
Amsacrine—TOP2A—Idarubicin—Doxorubicin—pancreatic cancer	0.000118	0.0148	CbGdCrCtD
Amsacrine—TOP2A—Daunorubicin—Doxorubicin—pancreatic cancer	0.000118	0.0148	CbGdCrCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000118	0.00149	CbGpPWpGaD
Amsacrine—Rash—Docetaxel—pancreatic cancer	0.000118	0.000447	CcSEcCtD
Amsacrine—Hypotension—Epirubicin—pancreatic cancer	0.000118	0.000447	CcSEcCtD
Amsacrine—Dermatitis—Docetaxel—pancreatic cancer	0.000118	0.000447	CcSEcCtD
Amsacrine—Confusional state—Doxorubicin—pancreatic cancer	0.000118	0.000447	CcSEcCtD
Amsacrine—Headache—Docetaxel—pancreatic cancer	0.000117	0.000445	CcSEcCtD
Amsacrine—Infection—Doxorubicin—pancreatic cancer	0.000116	0.00044	CcSEcCtD
Amsacrine—NCOA3—Metabolism—CD44—pancreatic cancer	0.000116	0.00147	CbGpPWpGaD
Amsacrine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000114	0.000434	CcSEcCtD
Amsacrine—Tachycardia—Doxorubicin—pancreatic cancer	0.000114	0.000432	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.000113	0.00144	CbGpPWpGaD
Amsacrine—Skin disorder—Doxorubicin—pancreatic cancer	0.000113	0.00043	CcSEcCtD
Amsacrine—Paraesthesia—Epirubicin—pancreatic cancer	0.000113	0.00043	CcSEcCtD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—MYC—pancreatic cancer	0.000113	0.00143	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—CTNNB1—pancreatic cancer	0.000113	0.00143	CbGpPWpGaD
Amsacrine—Dyspnoea—Epirubicin—pancreatic cancer	0.000112	0.000427	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000112	0.00142	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000112	0.00141	CbGpPWpGaD
Amsacrine—Anorexia—Doxorubicin—pancreatic cancer	0.000111	0.000422	CcSEcCtD
Amsacrine—Nausea—Docetaxel—pancreatic cancer	0.000111	0.000422	CcSEcCtD
Amsacrine—NCOA3—Metabolism—GCG—pancreatic cancer	0.000111	0.00141	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MMP9—pancreatic cancer	0.00011	0.0014	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.00011	0.00139	CbGpPWpGaD
Amsacrine—Decreased appetite—Epirubicin—pancreatic cancer	0.00011	0.000416	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.00011	0.00139	CbGpPWpGaD
Amsacrine—Hypotension—Doxorubicin—pancreatic cancer	0.000109	0.000414	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000109	0.000413	CcSEcCtD
Amsacrine—Fatigue—Epirubicin—pancreatic cancer	0.000109	0.000413	CcSEcCtD
Amsacrine—Pain—Epirubicin—pancreatic cancer	0.000108	0.000409	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000107	0.00135	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000106	0.00134	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000106	0.00134	CbGpPWpGaD
Amsacrine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000105	0.000398	CcSEcCtD
Amsacrine—NCOA3—Metabolism—STK11—pancreatic cancer	0.000104	0.00132	CbGpPWpGaD
Amsacrine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000104	0.000395	CcSEcCtD
Amsacrine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000104	0.000394	CcSEcCtD
Amsacrine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000103	0.000391	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000103	0.0013	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—TYMS—pancreatic cancer	0.000103	0.0013	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—SRC—pancreatic cancer	0.000102	0.00129	CbGpPWpGaD
Amsacrine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000101	0.000385	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000101	0.000382	CcSEcCtD
Amsacrine—Fatigue—Doxorubicin—pancreatic cancer	0.000101	0.000382	CcSEcCtD
Amsacrine—Urticaria—Epirubicin—pancreatic cancer	0.0001	0.00038	CcSEcCtD
Amsacrine—Pain—Doxorubicin—pancreatic cancer	9.98e-05	0.000379	CcSEcCtD
Amsacrine—Abdominal pain—Epirubicin—pancreatic cancer	9.97e-05	0.000378	CcSEcCtD
Amsacrine—Body temperature increased—Epirubicin—pancreatic cancer	9.97e-05	0.000378	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—VEGFA—pancreatic cancer	9.91e-05	0.00126	CbGpPWpGaD
Amsacrine—TOP2A—Azacitidine—Gemcitabine—pancreatic cancer	9.89e-05	0.0123	CbGdCrCtD
Amsacrine—TOP2A—Circadian rythm related genes—PTEN—pancreatic cancer	9.88e-05	0.00125	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—STAT3—pancreatic cancer	9.82e-05	0.00124	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.8e-05	0.00124	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—NRAS—pancreatic cancer	9.79e-05	0.00124	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—BRCA2—pancreatic cancer	9.64e-05	0.00122	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	9.63e-05	0.00122	CbGpPWpGaD
Amsacrine—Feeling abnormal—Doxorubicin—pancreatic cancer	9.62e-05	0.000365	CcSEcCtD
Amsacrine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	9.55e-05	0.000362	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	9.54e-05	0.00121	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	9.47e-05	0.0012	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	9.3e-05	0.00118	CbGpPWpGaD
Amsacrine—Hypersensitivity—Epirubicin—pancreatic cancer	9.29e-05	0.000353	CcSEcCtD
Amsacrine—Urticaria—Doxorubicin—pancreatic cancer	9.27e-05	0.000352	CcSEcCtD
Amsacrine—Body temperature increased—Doxorubicin—pancreatic cancer	9.23e-05	0.00035	CcSEcCtD
Amsacrine—Abdominal pain—Doxorubicin—pancreatic cancer	9.23e-05	0.00035	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—TYMS—pancreatic cancer	9.17e-05	0.00116	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—TGFB1—pancreatic cancer	9.1e-05	0.00115	CbGpPWpGaD
Amsacrine—Asthenia—Epirubicin—pancreatic cancer	9.05e-05	0.000343	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—TNF—pancreatic cancer	9.05e-05	0.00115	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—TYMS—pancreatic cancer	8.98e-05	0.00114	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—EGFR—pancreatic cancer	8.92e-05	0.00113	CbGpPWpGaD
Amsacrine—Diarrhoea—Epirubicin—pancreatic cancer	8.63e-05	0.000328	CcSEcCtD
Amsacrine—Hypersensitivity—Doxorubicin—pancreatic cancer	8.6e-05	0.000326	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	8.55e-05	0.00108	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	8.53e-05	0.00108	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—TNF—pancreatic cancer	8.5e-05	0.00108	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—KRAS—pancreatic cancer	8.43e-05	0.00107	CbGpPWpGaD
Amsacrine—Asthenia—Doxorubicin—pancreatic cancer	8.38e-05	0.000318	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	8.37e-05	0.00106	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	8.36e-05	0.00106	CbGpPWpGaD
Amsacrine—Dizziness—Epirubicin—pancreatic cancer	8.34e-05	0.000317	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	8.11e-05	0.00103	CbGpPWpGaD
Amsacrine—Vomiting—Epirubicin—pancreatic cancer	8.02e-05	0.000304	CcSEcCtD
Amsacrine—Diarrhoea—Doxorubicin—pancreatic cancer	7.99e-05	0.000303	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—TERT—pancreatic cancer	7.99e-05	0.00101	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	7.97e-05	0.00101	CbGpPWpGaD
Amsacrine—Rash—Epirubicin—pancreatic cancer	7.95e-05	0.000302	CcSEcCtD
Amsacrine—Dermatitis—Epirubicin—pancreatic cancer	7.95e-05	0.000302	CcSEcCtD
Amsacrine—Headache—Epirubicin—pancreatic cancer	7.9e-05	0.0003	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	7.9e-05	0.001	CbGpPWpGaD
Amsacrine—Dizziness—Doxorubicin—pancreatic cancer	7.72e-05	0.000293	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	7.64e-05	0.000967	CbGpPWpGaD
Amsacrine—Nausea—Epirubicin—pancreatic cancer	7.49e-05	0.000284	CcSEcCtD
Amsacrine—Vomiting—Doxorubicin—pancreatic cancer	7.42e-05	0.000282	CcSEcCtD
Amsacrine—Rash—Doxorubicin—pancreatic cancer	7.36e-05	0.000279	CcSEcCtD
Amsacrine—Dermatitis—Doxorubicin—pancreatic cancer	7.35e-05	0.000279	CcSEcCtD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	7.33e-05	0.000928	CbGpPWpGaD
Amsacrine—Headache—Doxorubicin—pancreatic cancer	7.31e-05	0.000277	CcSEcCtD
Amsacrine—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	7.31e-05	0.000925	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—APOE—pancreatic cancer	7.31e-05	0.000925	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	7.26e-05	0.000919	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—HRAS—pancreatic cancer	7.16e-05	0.000907	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	7.16e-05	0.000907	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	7.1e-05	0.000899	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	7.02e-05	0.000889	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	6.97e-05	0.000883	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—RB1—pancreatic cancer	6.95e-05	0.00088	CbGpPWpGaD
Amsacrine—Nausea—Doxorubicin—pancreatic cancer	6.93e-05	0.000263	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.92e-05	0.000875	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—TP53—pancreatic cancer	6.74e-05	0.000854	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CG—pancreatic cancer	6.59e-05	0.000835	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PPARG—pancreatic cancer	6.36e-05	0.000806	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—AKT1—pancreatic cancer	6.33e-05	0.000801	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—RB1—pancreatic cancer	6.21e-05	0.000787	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	6.2e-05	0.000785	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	6.11e-05	0.000774	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	5.93e-05	0.000751	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CD—pancreatic cancer	5.8e-05	0.000734	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	5.69e-05	0.000721	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN2A—pancreatic cancer	5.46e-05	0.000692	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TNF—pancreatic cancer	5.32e-05	0.000673	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	5.28e-05	0.000669	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CCND1—pancreatic cancer	5.16e-05	0.000654	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	5.06e-05	0.00064	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CB—pancreatic cancer	5.05e-05	0.00064	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTGS2—pancreatic cancer	5.01e-05	0.000634	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—HRAS—pancreatic cancer	4.79e-05	0.000607	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CCND1—pancreatic cancer	4.62e-05	0.000584	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.61e-05	0.000584	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	4.57e-05	0.000579	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTEN—pancreatic cancer	4.37e-05	0.000553	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MYC—pancreatic cancer	4.14e-05	0.000524	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	3.89e-05	0.000492	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PRSS1—pancreatic cancer	3.79e-05	0.000479	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MYC—pancreatic cancer	3.7e-05	0.000469	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	3.61e-05	0.000457	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	3.57e-05	0.000452	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	3.51e-05	0.000445	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	3.48e-05	0.00044	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	3.39e-05	0.000429	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ARG2—pancreatic cancer	3.28e-05	0.000416	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	3.14e-05	0.000398	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ARG2—pancreatic cancer	3.09e-05	0.000392	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CA—pancreatic cancer	3.08e-05	0.00039	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	3.06e-05	0.000388	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TP53—pancreatic cancer	3.04e-05	0.000385	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TYMP—pancreatic cancer	2.87e-05	0.000363	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.82e-05	0.000357	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.81e-05	0.000356	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.75e-05	0.000349	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TYMP—pancreatic cancer	2.7e-05	0.000342	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.62e-05	0.000332	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.6e-05	0.000329	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AKT1—pancreatic cancer	2.52e-05	0.000319	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.39e-05	0.000303	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GLP1R—pancreatic cancer	2.31e-05	0.000293	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.31e-05	0.000293	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—DPYD—pancreatic cancer	2.28e-05	0.000288	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	2.18e-05	0.000276	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	2.16e-05	0.000273	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—DPYD—pancreatic cancer	2.14e-05	0.000272	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	2.03e-05	0.000258	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.95e-05	0.000247	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CD44—pancreatic cancer	1.67e-05	0.000212	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GCG—pancreatic cancer	1.6e-05	0.000203	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CD44—pancreatic cancer	1.58e-05	0.0002	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GCG—pancreatic cancer	1.51e-05	0.000191	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—STK11—pancreatic cancer	1.51e-05	0.000191	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—STK11—pancreatic cancer	1.42e-05	0.00018	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TYMS—pancreatic cancer	1.3e-05	0.000164	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.22e-05	0.000155	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—APOE—pancreatic cancer	1.05e-05	0.000134	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—APOE—pancreatic cancer	9.94e-06	0.000126	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	9.52e-06	0.000121	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPARG—pancreatic cancer	9.19e-06	0.000116	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	8.97e-06	0.000114	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPARG—pancreatic cancer	8.66e-06	0.00011	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	8.37e-06	0.000106	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	7.88e-06	9.98e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	7.29e-06	9.23e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTGS2—pancreatic cancer	7.23e-06	9.15e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	6.87e-06	8.7e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	6.81e-06	8.62e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTEN—pancreatic cancer	6.3e-06	7.98e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTEN—pancreatic cancer	5.94e-06	7.52e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	4.45e-06	5.63e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	4.19e-06	5.3e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AKT1—pancreatic cancer	3.63e-06	4.6e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AKT1—pancreatic cancer	3.42e-06	4.33e-05	CbGpPWpGaD
